Trial Profile
Long Term, Single-arm, Open-label Extension Study of the MUSIC Study to Assess the Safety and Tolerability of Macitentan in Patients With Idiopathic Pulmonary Fibrosis
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 29 Oct 2014
Price :
$35
*
At a glance
- Drugs Macitentan (Primary)
- Indications Idiopathic pulmonary fibrosis
- Focus Adverse reactions
- Acronyms MUSIC OL
- Sponsors Actelion Pharmaceuticals
- 13 Aug 2014 New trial record
- 12 Sep 2011